ADVERTISEMENT
News
MS Medication Recalled
07/17/2020
The recall affects Tecfidera (dimethyl fumarate) delayed-release capsules, 60-count bottles (NDC 64406-006-02), from lot SH0274 (Exp. 2/22). Nearly 4000 bottles were distributed to wholesalers in Kentucky, Ohio, and Mississippi.
Biogen voluntarily initiated the recall June 23, 2020. The FDA designated the recall Class III on July 9, 2020, suggesting use of the affected capsules is not likely to cause harm.
Tecfidera is a prescription medicine used to treat relapsing forms of multiple sclerosis in adults.
—Jolynn Tumolo